Pfizer's PREVNAR 20™ Selected for Québec's Publicly Funded Pediatric Pneumococcal Immunization Program
Breadcrumb Trail Links PR Newswire Pfizer Canada Inc. CNW Article content KIRKLAND, QC, July 29, 2026 /CNW/ — Pfizer Canada ULC is pleased to announce that its 20-valent pneumococcal conjugate vaccine, PREVNAR 20™ has been selected for the publicly …